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Abstract-The total synthesis of alamethicin I by solution phase methods is reported. 
The microbial peptide alamethicin has aroused con- 
siderable interest due to its membrane-modifying pro- 
perties. The polypeptide is known to lyse cells,' cause 
fusion of liposomes' and has been used to study sided- 
ness of natural membranes.s5 A particularly interesting 
property of alamethicin is its ability to induce excitability 
in artificial lipid bilayer systems.6 While extensive stu- 
dies on the transport properties of alamethicin channels 
in membranes have been there has been 
some confusion regarding the primary structure of 
alamethicin.'G'2 The original cyclic structure postulated 
by Payne et a1." was found incompatible with 270MHz 
'H NMR data." Martin and Williams then proposed an 
acyclic structure" and this sequence was further modified 
by Pandey er 01. '~  The studies on alamethicin have been 
hampered by the heterogenous nature of the material from 
natural sources. In a recent report Marshall and Balasu- 
bramaniani3 have shown that the alamethicin used €or 
biological studies has eight components. However they 
have identified the major component as having a structure 
similar to the one proposed by Pandey et al. (Fig. I ) .  
Alamethicin I is characterised by the presence of a large 
number of sterically hindered14 a-aminoisobutyric acid 
(Aib)t residues and an alcohol derived from L-Phe at the 
C-terminal. In order to probe the secondary structure of 
alamethicin and thereby develop models for its membrane 
activity, a program was initiated to study synthetic 
alamethicin fragments and model Aib peptides by spec- 
trocopy'S-'8 and X-ray crystallography.'s22 In this paper 
we report the total synthesis of alamethicin I by solution 
phase methods. 
Outline of synthetic scheme 
The scheme for the synthesis of the amino terminal 
hexapaptide is shown in Fig. 2. The tripeptides 2 A i b -  
PrhAib-OH and Boc-Ala-Aib-Ala-OMe were syn- 
thesised stepwise. The hexapaptide was obtained by 
coupling Z-Aib-Pro-Aib-OH to H2N-Ala-Aib-Ala- 
OMe in DMF with DCC and HOBT. The 7-13 fragment 
*Address for correspondence. 
t Aib. a-arninoisobutryic acid; Ac, acetyl; Boc, t-butyloxy- 
carbonyl; DCC, N,Ndicyclohexylcarbiimide; DMF, dimethyl- 
formamide; HOBT, I-hydroxybenzotriazole; H O W ,  N-hydroxy- 
succinimide; OBzl, benzyl ester: OMe, methyl ester, 
Phol(phenyla1aninol); POE, polyoxyethylene. 
was synthesised from Boc-Gln-AibOBzl, Boc-Val- 
Aib-OMe and Boc-Gly-Leu-Aib-OMe as shown in Fig. 3. 
In the synthesis of Boc-Gln-Aib-OBzl, HOBT was 
added to prevent dehydration of the side chain amide of 
Gln, during DCC activation.23 Hydrogenolysis of the 
dipeptide was achieved by catalytic transfer hydro- 
genation using palladium black and cycl~hexene.~' The 
14-17 tetrapeptide was synthesised by coupling Boc-Pro 
to H2N-Val-Aib-AiMMe as shown in Fig. 4. Boc-Val- 
Aib-OH was coupled to Aib-OMe in DMF with DCC and 
HOBT. The coupling did not proceed to give the tripep- 
tide when only DCC was used. Instead the corresponding 
oxazolone was obtained, which was characterised by the 
IR band= at 1820 cm-'. Boc-y-benzyl Glu-Gln was syn- 
thesised by the active ester method using HOSU and 
coupled to Phol to give the 17-20 fragment of alamethi- 
cin (Fig. 5).  The major fragments were coupled as shown 
in Fig. 6. Throughout the synthesis amino acid and 
peptide free bases were used instead of the acid salts 
accompanied by in situ neutralisation. Schemes involv- 
ing dipeptide fragments of Aib were not used as their 
deprotection lead to the formation of corresponding 
diketo-piperazines.26 An important observation during 
the course of the synthesis was the detection of exten- 
sive racemisation by NMR in sequences R-Aib-X- 
COOH (X is an optically active amino acid) when only 
DCC was used as the coupling reagent.27 However, 
optically pure peptides were obtained when HOBT was 
used as an additive. 
Charactensation of peptide fragments 
The various peptide fragments obtained during the 
course of alamethicin synthesis were characterised by 
elemental analysis and in the case of larger fragments by 
amino acid analysis and high field 'H and I3C NMR. The 
C, H, N analysis obtained for the various fragments are 
summarised in Table 1. The largest fragment for which 
elemental analysis was obtained was the 1-13 fragment. 
In every case, the results were satisfactory. The amino 
acid analysis data on the larger fragments are sum- 
marked in Table 2. Satisfactory results for all the amino 
acids were obtained. Ratios for Aib could not be 
obtained due to low colour value of sterically hindered 
Aib. The 270 MHz 'H NMR" spectra were fully con- 
sistent with the structures and yielded satisfactory in- 
tegrals for the various groups of hydrogens. Detailed 
conformational analysis of the 1-6 and 7-13 fragments 
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Fig. 6. Scheme for the condensation of 1-6, 7-13, 14-17 and 18-20fragments. 
have been completed by NMR. 67.89 MHz "C spectra" 
of the alamethicin fragments also supported the assigned 
structures. While 'H and 13C NMR have been exten- 
sively used in organic chemistry, their routine application 
to the monitoring of peptide synthesis has been a rela- 
tively recent phenomenon. This has in part been aided by 
the availability of high field Fourier Transform NMR 
spectrometers that afford both the sensitivity and chem- 
ical shift resolution that are necessary in studies of oligo 
peptides. Examples stressing application of NMR to the 
monitoring of peptide synthesis2'* r, have appeared in the 
literature. 
Characterisation of synthetic alamethicin 
Synthetic alamethicin was characterised by amino acid 
analysis and comparison of its tlc, CD and UV spectra 
with natural alamethicin. The synthetic and natural pep- 
tides were also compared for their ability to 
render liposomes permeable to cations. In 
chloroform/methanol/water 65 : 24:4, synthetic 
alamethicin showed a spot at Rf = 0.56 (silica gel) and a 
faint spot at R, = 0.60. Natural alamethicin had a Rf of 
0.56 in this solvent system. In n-butanollacetic 
acidlwater (4: 1: I), synthetic alamethicin showed a spot 
at Rf = 0.44 and a faint spot at R, = 0.80 compared to a 
R, = 0.48 of natural alamethicin. The spots were visu- 
alised by staining with iodine. The amino acid analysis 
for synthetic alamethicin is summarised in Table 2. 
Satisfactory results for all the amino acids were 
obtained. As in the case of fragments, ratios for Aib 
could not be obtained due to low colour value of Aib. 
Hence, only relative values of Aib in the 1-17 fragment 
and alamethicin normalised with respect to Gly is repor- 
ted. Phol could not be detected under the conditions 
used for amino acid analysis. In fact Gisin el a1?* have 
used a buffer of pH 10 to identify Phol. However the 
presence of Phol is easily identified from UV (Fig. 7) and 
NMR. The CD spectra of synthetic and natural 
alarnethicinM are shown in Fig. 8. Small differences in 
the spectra of the natural and synthetic peptides could 
possibly arise from the heterogeneity of the natural 
material, which is contaminated by closely related poly- 
peptides. However, the synthetic and natural peptides 
compare reasonably well. The cation translocating 
Table I .  Elemental analysis of the fragments of alamethicin I 
Pep t ide  Calculated Found C S L H X N X  c Y M  ML 
Z-AibcPro -Aib -Ol . ; e  3. 
B o c - M a - X l b - A l a - O E l e  1 
Z - A l b - P r o - A l b - A l  a- Aib- Ala- OH 9 
Boc-Cln-Aib-CBz 1 2 
B o c - G l y - L e u - A l b - O M e  16 
Boc-Val-AiS4ly-Leu-Alb-OMe 11 
Boc-Gln-Xib-Val-Aib41y-Leu-Aib-OMe 
B oc-V a1 -Alb-Ai b-OPie 
BOC-T -benzyl Glu-Gln-Phol 22 
Z-(1-13)-4Me 2 
2 
60.96 
53.46 
57.47 
58.66 
56.78 
55.79 
56.23 
56.84 
62 .19  
56.70 
7 .16 
8.30 
7.17 
7.63 
8.64 
8.58 
8 .39 
8.79 
7.07 
7.62 
9.70 
11.69 
13 .OO 
10.26 
12.25 
10.85 
14.57 
10.47 
9.36 
14.94 
61.32 
52.97 
57.31 
513.53 
56.96 
55.44 
55.78 
57.20 
62.59 
56.28 
7 . 2 9  
8.50 
7.60 
7 .87 
8.49 
8 .78  
8.74 
0.40 
7.51 
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Fig. 7. UV spectra of (a) Natural alamethicin (b) Synthetic 
alamethicin in methanol at 20", I mg/ml. 
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Fig. 8. CD spectra of (a) Synthetic alamethicin (b) Natural 
alamethicin; in trifluoroethanol at 20", 0.2 mM. 
effects of synthetic and natural alamethicin3' in uni- 
lamellar egg lecithin vesicles, monitored by time depen- 
dent changes in Ca2'-chlorotetracycline fluorescence is 
shown in Fig. 9. A good correlation is clearly seen 
between the synthetic and natural peptides. While a well 
resolved 'H NMR spectrum of alamethicin could not be 
obtained even at 270 MHz, peaks corresponding to 
aromatic protons of Phol -76 and acetyl protons -26 
were clearly discernable. Earlier reports describing the 
NMR of natural alamethicin" used the convolution 
difference technique to enhance resolution. 
A very useful feature of Aib containing peptides is 
their relatively restricted range of backbone confor- 
mations. The reduction in conformational freedom im- 
posed by the presence of Aib residues facilitates the 
ready crystallisation of many peptides. As a consequence 
even large fragments could be purified by crystallisation. 
The availability of single crystals provides a method for 
the determination of molecular weights by X-ray diffrac- 
tion if accurate cell parameters and crystal densities can 
be obtained. The crystal data for some synthetic frag- 
ments of alamethicin are listed in Table 3. For the amino 
terminal Id and 1-13 fragments, molecular weights 
obtained were 649 and 1412.5. While the agreement is 
good for the Id fragment with the calculated mol wt of 
660, the slightly higher mol wt of the 1-13 fragment 
obtained from the crystal as compared to the calculated 
mol wt of 1312 may be due to the cocrystallisation of 
solvent molecules. The mol wt obtained for synthetic 
alamethicin was 1852. The calculated value is 1960. The 
mol wt determined by X-ray crystallography is based on 
an assumed density of 1.25 for the crystal. Actual density 
measurements were not carried out as only one or two 
good single crystals were available. However the expec- 
ted error is about 2100. The X-ray results, together with 
the spectroscopic and amino acid analysis confirm that 
Table 2. Amino acid analysis of the fragments of alamethicin I 
Peptide.  u a  Glx Gly L a  Pro V a l  M b  
B o c 4  1 n-Atb-Val - A l M l y - L s u -  
Aib-CUe 
Synthetic alamathicin 27 
- 1.00 1-00 1.17 - 0.91 - 
(1.00l (1.00) (1.00) (1 .OO) 
2.25 0.86 1.00 0.07 1.11 0 . 8 2  2.20b 
(2.00) (1.00) (1.00) (1.00) (1.00) (1.00) 
2.18 0.92 1.00 0.92 2.20 2.26 1.07' 
(2.00) (1.00) (1.00) (1.00) (2.00) (2.00) 
1.82 2 . 8 6  1.00 0.92 1.60 1.83 - 
(2.00) (3 .OO) (1 .OO) (1 .OO) ( 2  .OO) ( 2  -00)  
a Numbers i n  brackets are theoretical values. 
Aib value i s  the rat io  Aib (1-13 fragment ;?1)/Aib (7-13 fragment Is) 
normalised with respect to Gly. 
Aib value is tne rat io  Aib (1-17 fragment %)/fib (Synthetic alamethicin 3)  
normalised with respect to S l y .  
the synthetic product corresponds to alamethicin I 
sequence. 
The synthesis of alamethicin reported in this paper 
differs in several respects from the solid phase synthesis 
reported by Gisin el al.32-33 and the synthesis of amino 
terminal 1-11 peptide by the POE metbod by Mayr et 
a/." In the former, a combination of stepwise and frag- 
ment couplings was adopted and a large excess of pro- 
tected amino acid derivatives and peptide fragments was 
used to ensure complete coupling. Further, extensive 
purification of the fragments and the final product by 
chromatography was necessary. Aib was quantitated by 
using small amounts of "C labelled Aib in the synthesis. 
The synthesis by Gisin et although elegant tums 
out to be fairly expensive, due to the large excess of 
fragments used and the sophisticated monitoring system. 
In the synthesis of the 1-11 amino terminal fragment of 
alamethicin by Mayr e? aLY purification of the POE 
bound peptide esters was easily effected by precipitation. 
However, as in the case of solid phase synthesis, large 
Table 3. Crystal data for the fragments of alamethicin I 
Paptide Molecular weight calculatsd obpsmod D e n s i t y  Space gmup C e l l  paranwters 
a = 10.96 S 
b - 11.781 51 
c = 28.006 R 
2-Mb-Pro-Alb-Ma- 66 0 648 1.20 p212121 
MbAla-OMe S 
a 9.92 R 
b - 16.23 2-Aib-Pro-Aib-Al a- 6 4 5  6 70 1.24 p21 2121 N b- A l e- O H  2 
c u 22.01 P 
a = 28.08 61 
b a 22.14 g 
c P 23.82 g 
Z-(l-l3)-OMe 23 1312 1412.4 l.2Ob P212121 
a 0 7 .75  R 
b - 18.53 R p2 1 Synthetic ala- 1960 1052 1 . 2 O b  methicin 2_1 
c - 35.66 
1- 93.2. 
a X-ray data for the peptides were provided by Dr.N.Shamala from t h i s  laboratory. 
asmec~ density. 
excess of amino acid derivatives were used in the syn- 
thesis. In the synthetic approaches to alamethicin repor- 
ted in this paper, good yields were obtained with equi- 
molar amounts of the amino acid derivatives and peptide 
fragments as compared to the studies of Gisin et ~ l . ' * * ~ '  
and Mayr et aLu Extensive use of chromatographic 
methods for the pudkation of the peptides was not 
necessary as pure peptides could be obtained by routine 
crystallisations. An important aspect of the present syn- 
thesis is that the fragments could be used for further 
conformational studies by spectroscopic and crystallo- 
graphic methods. 
EXPERIMENTAL 
M.ps reported are uncorrected. Optical rotations were recor- 
ded in a Jobin Yvon polarimeter at 589nm. CD spectra were 
recorded using a Jasco J-20 spectropolarimeter. Micro analysis 
and amino acid analysis were obtained through the courtesy of 
Department of Organic Chemistry, Indian Institute of Science, 
Bangalore, India and Dr. G .  M. Anantharamiah of Ohio State 
University, Columbus, USA. respectively. Crystal parameters 
were measured in this laboratory by R. N. Shamala. Natural 
alamethicin was obtained as a gift from Dr. G. E. Grady, The 
Upjohn Company, Michigan, USA. 
Boc and benzyloxycarbonyl amino acids were prepared by 
conventional procedures. Amino acid methyl esters were pre- 
pared as follows: The methyl ester hydrochloride" was dissolved 
in sat Na2COI aq and extracted with CHC13. On drying and 
evaporating the organic layer, the free base ester was obtained as 
an oil. AU peptides were checked for homogeneity by tlc on silica 
gel using S% and 10% MeOH/CHC13 for amino protected peptide 
esters and n-BuOH/AcOH/water 4: 1:l for amino protected pep- 
tide acids. The peptide free base esters were checked for purity 
by tlc on silica1 gel by iodine and ninhydrin visualisation and 
used without further purification. The protected peptides were 
also checked by 270 MHz 'H and 67.89 ''C NMR. 
Synthesis of Z-Aib-Pr&Aib-Ala-AibAla-OH 
Z-Aib-Pro-OMe 1. Z A i b  (2.6g, 10mmol) was dissolved in 
CH2C12 (IS ml) and cooled to 0". Pro-OMe (1.5g, IOmmol) was 
added followed by DCC (2.16g, 10mmol). The mixture was 
stirred at room temp. overnight. The dicyclohexylurea (NU) 
was filtered off and the organic layer washed with IN HCI. H20, 
1 M NaHCO, and dried over Na2S04. The organic layer was 
evaporated to leave an oily residue. The oil solidified on keeping in 
the cold for several days, yield= 2.9g (80%); m.p. = 8548'; 
Lit =Oil"; [a]Ds = -87.5" (c = 0.2 in MeOH). 
ZAib-Pro-OH 2. The ester 2 (2.9 g, 8 mmol) was dissolved in 
MeOH (5 ml) and 2N NaOH (8 ml) added. After 12 hr at room 
temp., H20  (25 ml) was added and the aqueous layer extracted 
with EtOAc (4 x 25 ml). The aqueous layer was acidified with 1 N 
HCI and extracted with EtOAc 4X2Sml. On drying and 
evaporating the organic layer, the dipeptide was obtained as an 
oil, yield=t.l g (75%). 
Z-Aib-Pro-AiMMe 3. The tripeptide was obtained by coup- 
ling 2 (2.1 g, 7 mmol) to Aib-OMe (0.8 g, 7 mmol) in CH2C12 as in 
the case of 1. Evaporation of CH2C12 yielded an oily residue 
which solidified on trituration with petroleum ether. The com- 
pound was recrystallised from MeOH-cther, yield=2.1 g (75%); 
m.p. = 160' [a],= = -12.5" ( c  =0.2 in MeOH). 
ZAib-PrwAib-OH 4. The ester 3 (2.1 g) was saponified as in 
the case of 1 to give the tripeptide acid yield = 1.7g (85%); 
m.p. = 195"; [a]D= = - 12.5" (c  = 0.2 in MeOH). 
Boc-Alit-AiWMe 5. The dipeptide was obtained by coupling 
Boc-Ala (1.52 g. 8 mmol) to Aib-OMe (0.92 g, 8 mmol) as in the 
case of 1, yield = 1.8s (80%); m.p. = 82-84": [ahu = -30.2" (c = 
0.2 in MeOH). 
Boc-Ala-AIMH 6. The ester 5 (1.8 g) was saponified with 2 N 
NaOH-MeOH as in the case of 2 to give the acid, yield = 1.6g 
(90%); m.p. = 17oD; [a],= = -47.5" (c = 0.2 in MeOH). 
BocAla-AibAla-OMe 7. The acid 6 (1.6g, 6mmol) was 
coupled to Ala-OMe (0.620 gg, 6 mmol) as in the case of 3, yield 
= 1.51 g (70%); m.p. = 158"; [(?IDZ1 = -2.5" ( c  = 0.2 in MeOH). 
ZAibPro-Ai~Ala-AiCAla-OMe 8. The tripeptide 7 (1.1 g, 
3 mmol) was dissolved in 2 N HCI/THF. After 4 hr, the removal 
of Boc group was complete. The THF was evaporated, the 
residue dissolved in H20 and filtered to remove some undis- 
solved material. The aqueous layer was made alkaline with 
Na2C03 and extracted with CHCl, (3 x 10 ml). On drying and 
evaporating CHCI,, H2N-Ala-Aib-Ala-OMe was obtained as an 
oil. 
The acid 4 (Log, 2.4mmol) was dissolved in DMF (10ml) and 
cooled to 0". H2N-Ala-Aib-Ala-OMe (6.00 g, 2.4 mmol) in DMF 
(5ml). HOBT (0.325g. 2.4mmol) and DCC (O.SOOg, 2.4mmol) 
were added successively. After stirring at room temp. for 36 hr, 
the N U  was filtered off and the filtrate diluted with EtOAc 
(25 ml). The organic layer was washed with H20, 1 N HCI, H20. 
1 M NaHCO, and dried over Na2S04. On evaporating EtOAc, an 
oily residue was obtained, which solidified on triturating with 
petroleum ether and slight warming, yield = 1.0 g (60%); m.p. = 
88"; [a],,= = 10.0" (c = 0.2 in MeOH). 
Single crystals were obtained from methyl acetatelether. The 
cell parameters obtained from X-ray diffraction are summarised 
in Table 3. 
ZAibPro-AibAla-AibAla-OH 9. The ester 8 (0.700 g) was 
saponified as in the case of 2 to give the acid, yield = 0.6Oog 
(81%); m.p. = 220"; [&]D' = 20.0" (c = 0.2 in MeOH). Single 
crystals were obtained from MeOH/ether. The cell parameters 
obtained from X-ray diffraction are summarised in Table 3. 
SynlhesL of B o c - G l n - A i ~ V a l - A i ~ l y - ~ ~ A i W M e  
Boc-Gln-Aib-OBzl 10. Boc-Gln (2.0 g, 8 mmol) was dissolved 
in DMF (ISml) and cooled to 0". Aib-OBzl (1.7g, 8rnmol), 
HOBT (I.Mg, 8mmol), DCC (1.650g, 8mmol) were added suc- 
cessively and the mixture stirred at room temp. for 24hr. The 
DCU was then filtered off and the filtrate diluted with EtOAc 
(25 ml). The organic layer was washed with H20, I N HCl, HzO, 
1 M NaHCOl and dried over Na2S04. On evaporating EtOAc and 
triturating the residue with petroleum ether, the dipeptide ester 
was obtained as a solid, yield = 2.0g (63%); m.p. = 101"; = 
22.5" ( c  = 0.2 in MeOH). 
Boc-Glr+AiWH 11. The dipeptide 10 (2.0 g) was dissolved in 
EtOH (15 ml). Freshly prepared Pd black (O.l00g), cyclohexene 
(10 ml) were added and the s o h  refluxed for 2 hr. The soh was 
decanted to remove Pd black and evaporated. On triturating the 
residue with ether, the dipeptide acid was obtained, yield = 1.35 g 
(90%); m.p. = 176'; [ u ] , ~  = -27.5" (c  = 0.2 in MeOH). 
B o c - G l y - h A M e  12. Boc-Gly (3.08. I7 mmol) was coupled 
to Leu-OMe (2.5 g, 17 mmol) in CHzClz as in the case of 1. The 
dipeptide ester was obtained as an oil, yield = 4.4 g (85%). 
Boc-Gly-Leu-OH 13. The ester 12 (4.4g) was saponified as in 
the case of 2. On triturating the oily residue with petroleum 
ether, the dipeptide acid was obtained as a solid, yield =4.Og 
(95%); m.p. = 133'; [a]," = -21.0" ( c  = 0.2 in MeOH). 
Boc-Gly-Lell-Aib-OMe 14. The tripeptide was obtained by 
coupling Boc-Gly-Lcu-OH (2.3 g, 8 mmol) to A i W M e  (l.Og, 
8 mmol) in DMF as in the case of 10, yield = 1.6 g (62%); m.p. = 
112"; [a]D" = -37.5" (c = 0.2 in MeOH). 
Boc-Val-Aib-OMe 15. Boc-Val (1.74 g, 8 mmol) was coupled 
to A i M M e  (Log, 8mmol) in CH2C12 as in the case 1, yield= 
1.75 g (70%); m.p. = 115-1 18"; [a]D= = -27.5" (c = 0.2 in MeOH). 
Boc-VaCAib-OH 16. The dipeptide ester (1.759) was 
saponified as in the case of 12 to give the dipeptide acid, 
yield=1.6g (90%); m.p.=163-165"; (a],==-32.5" (c=0.2in 
MeOH). 
Boc-Val-Aib-Gly-Leu-AiMMe 17. Boc group was removed 
from 14 (1.54g) as in the case of 7. HzN-Gly-Lell-AiL+OMe 
( I  .2 g, 4 mmol) was coupled to Boc-GIn-Aib-OH (1.2 g,4 mmol) 
in DMF as in the case of 16, yield = 1.5 g (65%); m.p. = 154l55": 
[a]Dz = -32.5" (c  = 0.2 in MeOH). 
Boc-Gln-Aib-Val-AiM;ly-Lcu-AiWMe 18. H2N-Val-Aib 
Gly-Leu-Aib-OMe (obtained as in the case of 7 (0.940 g, 2 mmol) 
was coupled to B o c - G l b A i M H  (0.660 g. 2 mmol) in DMF, with 
DCC-HOBT as in the case of 18. yield = 1.0 g (55%); m.p. = 1 I& 
112'; = -20.0" (c  = 0.15 in MeOH). 
Synthesis of Boc-PrwVal-AiCAib-OMe and Boc-y-benzyl: 
Glu-Gln-Phol 
Boc-Val-Aib-Aib-OMe 19. Boc-VaLAiWH (1.5 g, 5 mmol) 
was coupled to Aib-OMe (0.650 8.5 mmol) as in the case of 10 in 
DMF, yield = 1.2 g (60%); m.pl = 140"; = -17.5 ( c  = 0.2 in 
MeOHI. 
Boc-Pro-Val-Aib-Aib-OMe 24. Boc-Pro (0.540 g, 2.5 mmol) 
was coupled to H2N-Val-AibAib-OMe (0.700 g, 2.5 mmol) 
(obtained as in the case of 7) in DMF with DCC-HOBT. The oily 
residue obtained after removing EtOAc, solidified after several 
hr in the cold, yield = 0.6g (5%): m.p. = 135": [a]Dz = -55.0" 
(c = 0.2 in MeOH). 
Boc-y-benzyl GlltGln 21. Boc-y-bentyWlu (3.0 g, 9 mmol) 
was dissolved in EtOAc (20 ml) and cooled to 4'. HOSU (0.945 g, 
9 mmol) and DCC (1.440 g, 9 mmol) were added and the mixture 
kept at 4' overnight. The N U  was filtered off and the filtrate 
washed with 1 N HCI, H20  and I M NaHC03. On drying and 
evaporating EtOAc the HOSU ester of Boc-y-benzyl Glu was 
obtained as a solid, yield = 2.6 g (66%). 
The Boc-y-benzyl Glu-OSu (2.6 g, 6 mmol) was dissolved in 
THF (10 mL) and a s o h  of Gln (O.88Og, 6 mmol), Et,N (0.84 ml, 
6 mmol) in HzO (10 ml) was added. After 12 hr at room temp. the 
THF was removed, the aqueous was acidified with 1 N HCI and 
extracted with EtOAc (3 x 20 ml). The organic layer was dried 
and evaporated. The oily residue was triturated with ether- 
EtOAc when the dipeptide was obtained as a solid, yield = 1.68 
(57%): m.p. = 125"; [alDZJ = -15.0" (c  = 0.2 in MeOH). 
Boc-y-benzyl Glu4ln-Phol 22. Phenylalaninol (PholI3' 
(0.380 g, 2.5 mmol) was added to a soln of 21 (1.16 8.2.5 mmol) in 
DMF at 0". HOBT (0.340g, 2.5 mmol). DCC (0.515 g, 2.5 mmol) 
were added and the mixture stirred at room temp. for 24 hr. The 
DCU was filtered off and the filtrate diluted with EtOAc (25 ml). 
TheorganiclayerwaswashedwithH20, I NHCl,H20, I MNaHCO, 
and dried. On evaporating the ethyl acetate, the tripeptide was 
obtained as a solid, yield -0.950g (60%); m.p. = 165°C: [a]Dz = 
-52.5" (c = 0.2 in MeOH). 
Synfhesis of Z A i ~ P r ~ A i ~ A l a - A i b A l a - G I n - A i ~ V a l - A i ~  
Gly-Leu-AiWMe ( U I - I U ) M e )  23 
Z-(ld)-OH 9 (0.575 g, 0.9 mmol) was coupled to HZN47-13b 
OMe (0.600g, 0.9mmol) (obtained by deprotection of 18 by 
HCllTHF as in the case of 7) in DMF with DCC-HOBT as in the 
case of 10, yield of the crude peptide = 0.700g (66%). 
The peptide was purified by column chromatography on silica 
gel (1.8 cm x 30 cm, 308 of silica gel). The peptide was eluted 
with 5% MeOH/CHC13, yield (after chromatography) = 
O.56Og (80%): m.p,=142-145'; [a]Dz=17.10 (c=0.25 in MeOH). 
Single crystals were obtained from MeOH. The cell parameters 
obtained X-ray diffraction are summarised in Table 3. 
Synthesis of ZAiCPro-AibAla -Ai~Ala -Gln-Ai~Val -Ai~  
Gly-Leu-Aib-Pro-Val-AibAiMMe 24 
The peptide 23 (0.56Sg) was saponified as in the case of 2 
with 2 N  NaOH to yield the Z(1-13) acid, yield =0.520g (90%); 
m.p. = 150-152". 
The Z( I-13racid (0.520 g, 0.45 mmol) was coupled to Pr+Val- 
Aib-Aib-OMe (0.390 g. 1.0 mmol) (obtitined by deprotection of 
u) as in the case of 7) in DMF with DCC-HOBT. Work up was 
as in the case of 10, yield of crude peptide = 0.500 g (74%). 
The peptide was purified by column chromatography on silica 
gel (1.8 cm x 30 cm, 25 g of silica gel). The desired peptide was 
obtained by elution with 5% MeOH/CHC13, yield = 0.450 g (90%); 
m.p. = 155-158'. 
Synthesis of A G A i C P r o - A i ~ A l a - A i ~ A l a ~ l n - A i C V a C A i ~  
Gly-Leu-AibPro-VaI-AibAib-OMe, Ac( I- I7jOMe 23 
Peptide 24 (0.130 g, 0.08 mmol) was dissolved in EtOH. Freshly 
prepared Pd black (0.100 g) and cyclohexene (5 ml) were added 
and the mixture refluxed for 1 hr with stirring. The Z-group was 
removed during the period of 1 hr. "he s o h  was decanted and 
evaporated. The residue was dissolved in CHC13 (15ml) were 
added and the mixture stirred at room temp. for 1 hr. The CHC13 
soh  was washed with 1 N HCI, H20  and dried. On evaporation 
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of CHC13, the desired compound was obtained, yield = 0.1 IS 8 
(90%); m.p. = 180". 
Ac-(I-I7)-OH 24. The peptide 25 was dissolved in MeOH 
(1  ml) and 2N NaOH (1 ml) added to it. After 6 hr, H20 (5 ml) 
was added and the aqueous soln was acidified with 2 N HCI. The 
aqueous layer was extracted with CHCI, ( 3  x 15 ml) and dried. 
The peptide acid obtained on evaporating CHCI, was used 
directly in the next step. 
Synthesis of alumethicin 27 
The Boc group was removed from 22 (0.120 g, 0.2 mmol) 
with 2N H C U H F  (1Oml). The hydrochloride was 
dissolved in DMF (5ml), cooled to 0" and Et,N (0.03 ml) 
added under stirring. After 20 min 26 (0.100 g, 0.6 mmol) 
was added followed by HOBT (O.OISg, 0.1 mmol) and DCC 
(0.0258, 0.1 mmol). The mixture was stirred at room temp. for 
48 hr. The DCU was filtered off and the filtrate diluted with 
CHCll (IS ml). The organic layer was washed with HzO. I N HCI 
H20, 1 M NaHC03 and dried CHCl, was evaporated and the 
residue dissolved in EtOH (IS ml). Freshly prepared Pd black 
(O.OSOg), cyclohexene (3 ml) were added and the mixture was 
refluxed for I hr with stirring. The EtOH s o h  was fhen decanted 
and evaporated. The residue was triturated with ether to give the 
desired compound, yield = 0.35 g (35%); m.p. = 237"; Lit (natural 
aIamethicin)'*=25%260", 275-279". 
Single crystals were obtained from MeOH. The cell parameters 
obtained from X-ray diffraction are summarised in Table 3. The 
characterisation of the peptide is described in the text. 
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